vs
太平洋生物科学（ASMB）与OptimumBank Holdings, Inc.（OPHC）财务数据对比。点击上方公司名可切换其他公司
OptimumBank Holdings, Inc.的季度营收约是太平洋生物科学的1.3倍（$13.6M vs $10.8M），OptimumBank Holdings, Inc.净利率更高（35.7% vs -85.2%，领先120.9%），太平洋生物科学同比增速更快（57.6% vs 32.0%），OptimumBank Holdings, Inc.自由现金流更多（$16.9M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
OptimumBank Holdings, Inc.是总部位于美国佛罗里达州的银行控股企业，旗下运营社区银行OptimumBank，面向佛罗里达州南部的个人消费者与中小企业，提供存款、各类贷款、财富管理等综合银行服务。
ASMB vs OPHC — 直观对比
营收规模更大
OPHC
是对方的1.3倍
$10.8M
营收增速更快
ASMB
高出25.6%
32.0%
净利率更高
OPHC
高出120.9%
-85.2%
自由现金流更多
OPHC
多$32.1M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $13.6M |
| 净利润 | $-9.2M | $4.9M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | 47.5% |
| 净利率 | -85.2% | 35.7% |
| 营收同比 | 57.6% | 32.0% |
| 净利润同比 | 4.3% | 22.9% |
| 每股收益（稀释后） | $-0.72 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBOPHC
| Q4 25 | — | $13.6M | ||
| Q3 25 | $10.8M | $13.0M | ||
| Q2 25 | $9.6M | $12.1M | ||
| Q1 25 | $9.4M | $10.7M | ||
| Q4 24 | $7.4M | $10.3M | ||
| Q3 24 | $6.8M | $10.1M | ||
| Q2 24 | $8.5M | $9.9M | ||
| Q1 24 | $5.8M | $9.0M |
净利润ASMBOPHC
| Q4 25 | — | $4.9M | ||
| Q3 25 | $-9.2M | $4.3M | ||
| Q2 25 | $-10.2M | $3.6M | ||
| Q1 25 | $-8.8M | $3.9M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | $-9.6M | $3.3M | ||
| Q2 24 | $-11.2M | $3.5M | ||
| Q1 24 | $-9.1M | $2.4M |
营业利润率ASMBOPHC
| Q4 25 | — | 47.5% | ||
| Q3 25 | -100.9% | 43.5% | ||
| Q2 25 | -115.2% | 40.2% | ||
| Q1 25 | -105.5% | 48.8% | ||
| Q4 24 | — | 51.5% | ||
| Q3 24 | -160.1% | 44.0% | ||
| Q2 24 | -143.0% | 46.9% | ||
| Q1 24 | -185.5% | 35.9% |
净利率ASMBOPHC
| Q4 25 | — | 35.7% | ||
| Q3 25 | -85.2% | 33.2% | ||
| Q2 25 | -105.9% | 29.8% | ||
| Q1 25 | -93.6% | 36.3% | ||
| Q4 24 | — | 38.3% | ||
| Q3 24 | -140.4% | 32.8% | ||
| Q2 24 | -130.7% | 35.2% | ||
| Q1 24 | -156.9% | 26.4% |
每股收益（稀释后）ASMBOPHC
| Q4 25 | — | $-0.08 | ||
| Q3 25 | $-0.72 | $0.18 | ||
| Q2 25 | $-1.33 | $0.29 | ||
| Q1 25 | $-1.17 | $0.32 | ||
| Q4 24 | — | $-0.17 | ||
| Q3 24 | $-1.51 | $0.15 | ||
| Q2 24 | $-1.98 | $0.34 | ||
| Q1 24 | $-1.66 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $121.9M |
| 总资产 | $240.0M | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBOPHC
| Q4 25 | — | — | ||
| Q3 25 | $22.5M | — | ||
| Q2 25 | $24.0M | — | ||
| Q1 25 | $23.4M | — | ||
| Q4 24 | $38.3M | — | ||
| Q3 24 | $28.5M | — | ||
| Q2 24 | $19.2M | — | ||
| Q1 24 | $18.7M | — |
股东权益ASMBOPHC
| Q4 25 | — | $121.9M | ||
| Q3 25 | $182.7M | $116.9M | ||
| Q2 25 | $18.1M | $111.3M | ||
| Q1 25 | $27.1M | $108.0M | ||
| Q4 24 | $33.4M | $103.2M | ||
| Q3 24 | $26.0M | $92.7M | ||
| Q2 24 | $34.7M | $87.0M | ||
| Q1 24 | $32.6M | $83.0M |
总资产ASMBOPHC
| Q4 25 | — | $1.1B | ||
| Q3 25 | $240.0M | $1.1B | ||
| Q2 25 | $80.8M | $999.1M | ||
| Q1 25 | $99.0M | $977.5M | ||
| Q4 24 | $119.2M | $932.9M | ||
| Q3 24 | $100.3M | $945.2M | ||
| Q2 24 | $115.3M | $899.8M | ||
| Q1 24 | $119.9M | $940.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $17.8M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $16.9M |
| 自由现金流率自由现金流/营收 | -140.7% | 124.6% |
| 资本支出强度资本支出/营收 | 0.4% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 3.68× |
| 过去12个月自由现金流最近4个季度 | — | $27.6M |
8季度趋势，按日历期对齐
经营现金流ASMBOPHC
| Q4 25 | — | $17.8M | ||
| Q3 25 | $-15.1M | $1.9M | ||
| Q2 25 | $-16.8M | $6.2M | ||
| Q1 25 | $-23.4M | $3.1M | ||
| Q4 24 | $-51.1M | $15.6M | ||
| Q3 24 | $-15.2M | $4.0M | ||
| Q2 24 | $-17.1M | $3.1M | ||
| Q1 24 | $-18.4M | $2.5M |
自由现金流ASMBOPHC
| Q4 25 | — | $16.9M | ||
| Q3 25 | $-15.2M | $1.9M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $2.9M | ||
| Q4 24 | $-51.1M | $14.6M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | $-17.1M | $2.7M | ||
| Q1 24 | $-18.4M | $2.3M |
自由现金流率ASMBOPHC
| Q4 25 | — | 124.6% | ||
| Q3 25 | -140.7% | 14.7% | ||
| Q2 25 | — | 48.5% | ||
| Q1 25 | — | 26.8% | ||
| Q4 24 | -695.2% | 141.9% | ||
| Q3 24 | — | 38.3% | ||
| Q2 24 | -200.6% | 27.5% | ||
| Q1 24 | -317.7% | 25.4% |
资本支出强度ASMBOPHC
| Q4 25 | — | 6.6% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.0% | 2.7% | ||
| Q4 24 | 0.4% | 9.6% | ||
| Q3 24 | 0.0% | 1.5% | ||
| Q2 24 | 0.2% | 3.6% | ||
| Q1 24 | 0.2% | 2.9% |
现金转化率ASMBOPHC
| Q4 25 | — | 3.68× | ||
| Q3 25 | — | 0.44× | ||
| Q2 25 | — | 1.71× | ||
| Q1 25 | — | 0.81× | ||
| Q4 24 | — | 3.95× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 0.89× | ||
| Q1 24 | — | 1.07× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
